Cargando…
Hyperglycemic Neurovasculature‐On‐A‐Chip to Study the Effect of SIRT1‐Targeted Therapy for the Type 3 Diabetes “Alzheimer's Disease” (Adv. Sci. 34/2022)
Neurovasculature‐On‐A‐Chip In article number 2201882, Minjeong Jang, Nakwon Choi, and Hong Nam Kim present a hyperglycemic neurovascular unit‐on‐a‐chip model that can recapitulate the pathologies of diabetes‐induced Alzheimers' disease. The neurovascular pathologies are mediated by SIRT1 and th...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9731707/ http://dx.doi.org/10.1002/advs.202270219 |
_version_ | 1784845961898491904 |
---|---|
author | Jang, Minjeong Choi, Nakwon Kim, Hong Nam |
author_facet | Jang, Minjeong Choi, Nakwon Kim, Hong Nam |
author_sort | Jang, Minjeong |
collection | PubMed |
description | Neurovasculature‐On‐A‐Chip In article number 2201882, Minjeong Jang, Nakwon Choi, and Hong Nam Kim present a hyperglycemic neurovascular unit‐on‐a‐chip model that can recapitulate the pathologies of diabetes‐induced Alzheimers' disease. The neurovascular pathologies are mediated by SIRT1 and thus could be rescued by the modulation of SIRT1 levels in each neuron and brain endothelial cell. [Image: see text] |
format | Online Article Text |
id | pubmed-9731707 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-97317072022-12-12 Hyperglycemic Neurovasculature‐On‐A‐Chip to Study the Effect of SIRT1‐Targeted Therapy for the Type 3 Diabetes “Alzheimer's Disease” (Adv. Sci. 34/2022) Jang, Minjeong Choi, Nakwon Kim, Hong Nam Adv Sci (Weinh) Inside Back Cover Neurovasculature‐On‐A‐Chip In article number 2201882, Minjeong Jang, Nakwon Choi, and Hong Nam Kim present a hyperglycemic neurovascular unit‐on‐a‐chip model that can recapitulate the pathologies of diabetes‐induced Alzheimers' disease. The neurovascular pathologies are mediated by SIRT1 and thus could be rescued by the modulation of SIRT1 levels in each neuron and brain endothelial cell. [Image: see text] John Wiley and Sons Inc. 2022-12-08 /pmc/articles/PMC9731707/ http://dx.doi.org/10.1002/advs.202270219 Text en © 2022 Wiley‐VCH GmbH https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Inside Back Cover Jang, Minjeong Choi, Nakwon Kim, Hong Nam Hyperglycemic Neurovasculature‐On‐A‐Chip to Study the Effect of SIRT1‐Targeted Therapy for the Type 3 Diabetes “Alzheimer's Disease” (Adv. Sci. 34/2022) |
title | Hyperglycemic Neurovasculature‐On‐A‐Chip to Study the Effect of SIRT1‐Targeted Therapy for the Type 3 Diabetes “Alzheimer's Disease” (Adv. Sci. 34/2022) |
title_full | Hyperglycemic Neurovasculature‐On‐A‐Chip to Study the Effect of SIRT1‐Targeted Therapy for the Type 3 Diabetes “Alzheimer's Disease” (Adv. Sci. 34/2022) |
title_fullStr | Hyperglycemic Neurovasculature‐On‐A‐Chip to Study the Effect of SIRT1‐Targeted Therapy for the Type 3 Diabetes “Alzheimer's Disease” (Adv. Sci. 34/2022) |
title_full_unstemmed | Hyperglycemic Neurovasculature‐On‐A‐Chip to Study the Effect of SIRT1‐Targeted Therapy for the Type 3 Diabetes “Alzheimer's Disease” (Adv. Sci. 34/2022) |
title_short | Hyperglycemic Neurovasculature‐On‐A‐Chip to Study the Effect of SIRT1‐Targeted Therapy for the Type 3 Diabetes “Alzheimer's Disease” (Adv. Sci. 34/2022) |
title_sort | hyperglycemic neurovasculature‐on‐a‐chip to study the effect of sirt1‐targeted therapy for the type 3 diabetes “alzheimer's disease” (adv. sci. 34/2022) |
topic | Inside Back Cover |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9731707/ http://dx.doi.org/10.1002/advs.202270219 |
work_keys_str_mv | AT jangminjeong hyperglycemicneurovasculatureonachiptostudytheeffectofsirt1targetedtherapyforthetype3diabetesalzheimersdiseaseadvsci342022 AT choinakwon hyperglycemicneurovasculatureonachiptostudytheeffectofsirt1targetedtherapyforthetype3diabetesalzheimersdiseaseadvsci342022 AT kimhongnam hyperglycemicneurovasculatureonachiptostudytheeffectofsirt1targetedtherapyforthetype3diabetesalzheimersdiseaseadvsci342022 |